AbbVie e Genmab recebem designação de terapia inovadora para tratamento de linfoma folicular recidivante ou refratário
28 November 2023 - 4:02AM
Newspaper
/jornal/2023/11/abbvie-e-genmab-recebem-designacao-de-terapia-inovadora-para-tratamento-de-linfoma-folicular-recidivante-ou-refratario/
Abbvie (BOV:ABBV34)
Historical Stock Chart
From May 2024 to Jun 2024
Abbvie (BOV:ABBV34)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Abbvie Inc (Brazil Bovespa Exchange): 0 recent articles
More News Articles